Andrea Paul - Net Worth and Insider Trading
Andrea Paul Net Worth
The estimated net worth of Andrea Paul is at least $458,917 dollars as of 2024-12-28. Andrea Paul is the Chief Legal Officer of Zentalis Pharmaceuticals Inc and owns about 149,973 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $458,917. Details can be seen in Andrea Paul's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrea Paul has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrea Paul
Andrea Paul Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrea Paul owns 2 companies in total, including LogicBio Therapeutics Inc (LOGC) , and Zentalis Pharmaceuticals Inc (ZNTL) .
Click here to see the complete history of Andrea Paul’s form 4 insider trades.
Insider Ownership Summary of Andrea Paul
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LOGC | LogicBio Therapeutics Inc | 2021-05-17 | General Counsel and Secretary |
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-02-02 | General Counsel |
Andrea Paul Latest Holdings Summary
Andrea Paul currently owns a total of 1 stock. Andrea Paul owns 149,973 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of February 2, 2024, with a value of $458,917.
Latest Holdings of Andrea Paul
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-02-02 | 149,973 | 3.06 | 458,917 |
Holding Weightings of Andrea Paul
Andrea Paul Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrea Paul has made a total of 1 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 3,310 shares on February 2, 2024, which brought Andrea Paul around $38,197.
Insider Trading History of Andrea Paul
- 1
Andrea Paul Trading Performance
Andrea Paul Ownership Network
Andrea Paul Owned Company Details
What does LogicBio Therapeutics Inc do?
Who are the key executives at LogicBio Therapeutics Inc?
Andrea Paul is the General Counsel and Secretary of LogicBio Therapeutics Inc. Other key executives at LogicBio Therapeutics Inc include Chief Scientific Officer Mariana Nacht , Chief Medical Officer Daniel Gruskin , and Interim CFO Joshua Blacher .
LogicBio Therapeutics Inc (LOGC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of LogicBio Therapeutics Inc (LOGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LogicBio Therapeutics Inc (LOGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
LogicBio Therapeutics Inc (LOGC)'s detailed insider trading history can be found in Insider Trading Tracker table.
LogicBio Therapeutics Inc Insider Transactions
Andrea Paul Mailing Address
Above is the net worth, insider trading, and ownership report for Andrea Paul. You might contact Andrea Paul via mailing address: 65 Hayden Avenue, 2nd Floor, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
